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Abstract
This review considers adipokines as predictive biomarkers for early onset post-traumatic knee
osteoarthritis (KOA). Serum concentrations of leptin and resistin can predict radiographic
changes and are elevated in early KOA, with higher leptin concentrations independently
associated with more severe knee changes. Plasma concentrations of resistin are chronically
elevated after injury. Leptin, resistin, chemerin and vistfatin induce catabolic enzymes
associated with cartilage degeneration. Available literature on adipokines in post-traumatic
KOA pathogenesis suggests that they could contribute to risk prediction of early onset
post-traumatic KOA. Further research is needed to further understand the association between
adipokines, synovitis and long-term outcomes in this population.
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Context
Adipokines are cytokines produced by white fat tissue in
response to a positive energy balance determined by food
intake. Obesity is a model of chronically elevated circulating
levels of pro-inflammatory adipokines. The biomechanical
aspects of increased body mass index (BMI) cannot explain the
high incidence of osteoarthritis (OA) in the non-weight-
bearing joints. Current concepts suggest that adipose tissue-
derived cytokines can increase inflammatory responses to
mechanical insults and result in fast progression to joint failure
(Oliveria et al., 1999). This article will review current literature
looking at the role of adipose tissue-associated inflammation in
the pathogenesis of post-traumatic knee osteoarthritis (KOA)
in the context of its impact on interactions between cartilage,
synovium and subchondral bone.
Methods
A comprehensive search of electronic databases was carried
out on Pubmed, the Cochrane Central Register of Controlled
Trials, CINAHL and reference lists of relevant articles. The
PubMed literature database was searched using MeSH index
terminology. The following broad search terms were included:
knee, post-traumatic and/or OA in combination with obesity,
adipokine or adiponectin. This was complimented by a hand
search of OA journals. This search was limited to human and
animal studies in the English language. Limits to publication
date applied between January 1985 and May 2014.
Systemic and local inflammation in post-traumatic
knee osteoarthritis
Systemic inflammation measured by IL-6 has been shown to
be an independent predictor of radiographic KOA in healthy,
middle-aged British women (Livshits et al., 2009). Knee
injury and obesity are strongly associated with the develop-
ment of KOA (Anderson & Felson, 1988; Davis et al., 1989;
Felson et al., 1988; Jiang et al., 2012; Lohmander et al., 2009;
Roos, 2005). Blagojevic et al. have estimated, through a meta-
analysis, that the overall pooled odd ratio (OR) for overweight
and obese individuals is 2.63 (95% CI 2.28–3.05) and 3.86
(95% CI 2.61–5.70) (Blagojevic et al., 2010) for those with
previous knee trauma. Obesity is characterized by high white
adipose tissue (WAT) mass and associated with a state of
chronic low-level inflammation. Anterior cruciate ligament
(ACL) or meniscal injuries are among the strongest risk
factors for early development of post-traumatic KOA
(Englund et al., 2003; Neuman et al., 2008; Roos, 2005;
von Porat, 2004). They represent a great model for the
development of KOA, with well-defined early onset of
disease. The incidence of all knee injuries is greatest in
males under 30 years of age (Gianotti et al., 2009; Majewski
et al., 2006). Joint injury may lead to a mild-to-moderate local
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inflammatory reaction (Pessler et al., 2008) and inflamed
knee synovium has been shown to be associated with more
severe cartilage degeneration over the course of a year (Ayral
et al., 2005). High systemic markers of inflammation have
been previously reported in patients with knee trauma
(Mendias et al., 2013).
Historically, the development of post-traumatic KOA in
humans with ACL-deficient knees has been mainly attributed
to recurrent episodes of knee instability. Primary ACL
reconstruction, aimed at restoring mechanical stability, has
not so far been proven to decrease the incidence of KOA or
improve long-term function in cohort or randomised con-
trolled studies (Barenius et al., 2014; Frobell et al., 2010,
2013; Lohmander et al., 2004; von Porat, 2004). It implies
that another mechanism might be responsible for driving joint
degeneration after initial trauma associated with instability.
Elevated BMI has been one of the strongest predictors of
early KOA development after ACL and/or meniscal injuries,
with an adjusted OR between 1.17 and 3.1 (Barenius et al.,
2014; Kessler et al., 2008; Lebel et al., 2008; Li et al., 2011).
Along with knee injury, other risk factors for the development
of KOA, age and female gender, are also associated with
increased systemic inflammation and a relatively higher
percentage of fat tissue (Pirkola et al., 2010).
The proposed overlapping common mechanism is an
adipose tissue-promoted inflammation. There is now increas-
ing evidence that, at least in a subset of the patients, both
inflammatory reactions of synovium and high adipokine
concentrations may be prevalent causes of early deterioration
of the knee joint (Guermazi et al., 2014; Karvonen-Gutierrez
et al., 2014; Roemer et al., 2011; Sokolove & Lepus, 2013). In
animal models, the effect of even extreme obesity on
development of KOA is diminished in animals without a
functional main adipokine pathway (Griffin et al., 2009).
Adipose tissue produces a series of chemicals that have
been linked with the regulation of systemic and organ-specific
inflammation, organ damage and chronic diseases like
diabetes (Bozaoglu et al., 2007; Fantuzzi, 2005;
MacDougald & Burant, 2007). It has been postulated that
increased systemic inflammation and activity of organ-
specific adipose stores promotes local inflammation. It has
also been suggested that, on the joint level, this results in
prolonged synovitis and affects the cartilage’s ability to
maintain an equilibrium between synthesis and degeneration
of cartilage constituents (Bao et al., 2010; de Boer et al.,
2012; Perruccio et al., 2014).
Signals from adipose tissue
Lipogenesis and lipolysis are two primary metabolic activities
of WAT (Cristancho & Lazar, 2011). Both processes are
regulated by endocrine and neural mechanisms. The discovery
of the first adipose tissue hormone, leptin, and an increased
interest in the endocrine functions of WAT have allowed for the
identification of cytokines known collectively as adipokines
(Ahima, 2006). The majority of these have been linked with
lipid metabolism but also with inflammation. Adipokines
associated with inflammation include classical pro-inflamma-
tory agents (IL-6, TNF-a) and tissue specific agents such as
leptin, adiponectin, Vaspin, Resistin, chemerin, visfatin and
adipsin. IL-6 produced by adipose tissue contributes to around
a third of circulating IL-6 and is strongly associated with
increasing obesity (Proenca et al., 2014).
Osteophytes are a structural hallmark of KOA and are
associated with knee pain. Individuals with higher BMIs have
an increased risk of fast cartilage loss (Roemer et al., 2009)
and report more severe knee pain (Weiss, 2014). High ratio of
fat mass to skeletal muscle mass is also positively associated
with more severe KOA structural changes on magnetic
resonance imaging (MRI) (Visser et al., 2014). Some
adipokines have been linked with development of more
severe knee changes (Karvonen-Gutierrez et al., 2014) and
more painful KOA (Perruccio et al., 2014). Similarly, patients
with a higher BMI are more likely to develop radiographic
KOA after anterior crucial ligament reconstruction (Li et al.,
2011). Secreted adipokines have also been shown to affect
bone cell differentiation and can potentially impact on bone
remodelling and bone formation (Bartell et al., 2011; Hamrick
et al., 2004; Muruganandan et al., 2010, 2013). Moreover,
bone marrow mesenchymal stem cells (MSCs) can differen-
tiate, not only into bone forming osteoblasts, but also into
adipocytes that can competitively suppress intracellular
osteogenic signals (Muruganandan & Sinal, 2014).
Leptin
Leptin is a hormone that is produced in proportion to WAT
mass and has been widely discussed in literature in the context
of pro-inflammatory properties in OA. Its concentration is
greater in women but it has not been entirely explained by
either adipose load or sex hormone concentrations (Licinio
et al., 1998). Apart from decreasing appetite, leptin promotes
neutrophil mobilisation, cytotoxic lymphocyte and macro-
phage activation (Carbone et al., 2012). It also enhances
production of MMP-1, MMP-3 and MMP-13 in human KOA
cartilage (Koskinen et al., 2011), resulting in a progressive
articular cartilage degeneration. The effect of leptin shows sex
dimorphism in the association of its effect with KOA. Higher
levels have been shown to be an independent predictor of MRI
and radiographic knee changes associated with OA, but
mainly in women.
Animal studies
Leptin has been shown to have both a strong anabolic and
catabolic function in chondrocytes. The anabolic function
occurs through the induction of IGF-1 and TGFb1 synthesis
(Dumond et al., 2003), while the catabolic function occurs by
inducing MMP1 and MMP13 expression with a concomitant
activation of STAT, MAPK, Akt and NF-kB signalling
pathways (Hui et al., 2012). Diet-induced obesity in mice
increases serum concentrations of leptin and KOA scores
(Griffin et al., 2012). Moreover, extreme obesity in animals
with impaired leptin signalling (leptin or leptin receptor
deficient) does not cause increased incidence of KOA (Griffin
et al., 2009). Leptin also affects bone metabolism and central
injection (intra-cerebroventricular administration) leads to
enhanced bone formation in a mutant leptin-deficient mouse
model (ob/ob mice) (Bartell et al., 2011).
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Human studies
Leptin receptors have been found to be expressed in articular
chondrocytes (Figenschau et al., 2001) and modulate expres-
sion of canonical Wnt signalling receptors (Ohba et al., 2010).
Synovial fluid (SF) and serum concentrations correlate with
BMI in patients with established KOA, while SF/serum ratio
is higher in early KOA (de Boer et al., 2012; Dumond et al.,
2003; Staikos et al., 2013). Unlike other adipokines, leptin
concentrations in SF are similar or higher than serum
concentrations (Presle et al., 2006). Higher plasma concen-
trations have been associated with greater painful joint burden
(Perruccio et al., 2014), with prevalent and incident KOA (OR
1.31, 95% CI 1.21–1.41), over a 10-year period in middle-
aged women (Karvonen-Gutierrez et al., 2013). In a 5-year
cohort study with very early-stage KOA, leptin has been
shown to be associated with higher levels of systemic markers
of synovial and cartilage metabolism and progression but not
with the incidence of radiographic KOA (Van Spil et al.,
2012). It has been cross-sectionally and longitudinally
associated with reduced cartilage thickness (Stannus et al.,
2013) and, interestingly, both obesity and female gender
effects have mainly been related to leptin (Ding et al., 2008).
Baseline levels have been associated with increased levels of
bone formation biomarkers (over 2 years) in patients with
established KOA (Berry et al., 2011). These have been
correlated with larger osteophyte formation, synovitis and
effusion on MRI (Karvonen-Gutierrez et al., 2014). Recently,
in women, higher leptin has been associated with 30%
higher risk of having structural KOA (Karvonen-Gutierrez
et al., 2012).
In summary, serum leptin levels have been positively
linked with KOA on a molecular level and in vivo,
both in animal models and human clinical studies.
This review has not identified any studies looking at the
role of leptin specifically in the development of post-
traumatic KOA.
Adiponectin
This adipokine modulates insulin sensitivity and inflamma-
tion. It has been shown to have both anti- and pro-
inflammatory properties, but its pivotal role is associated
with an inhibitory effect of proinflammatory cytokines, such
as tumour necrosis factor and interleukin-6 (IL-6). It is also
associated with the induction of expression of anti-inflam-
matory proteins, including IL-10 and IL-1 receptor antagonist
(Kumada et al., 2004; Tsatsanis et al., 2005; Wolf et al.,
2004). Females have higher circulating levels of adiponectin
than males (Combs et al., 2003). Visceral adipocytes are
mainly responsible for adiponectin’s systemic levels and,
paradoxically, those are reduced in obesity (Arita et al., 2012).
The transcription of adiponectin in adipocytes is suppressed
by TNF and IL-6, which might explain the lower levels of
serum adiponectin in obese individuals (Bruun et al., 2003;
Fasshauer et al., 2003; Maeda et al., 2002). Two types of
adiponectin receptor have been identified: AdipoR1, which
mainly activates the AMPK phosphorylation pathway and
AdipoR2, which is involved in the activation of PPAR-a (Lee
et al., 2008).
Animal studies
Adiponectin is effective in reducing the activation of
inflammatory pathways, including the NF-kB pathway
(Lira et al., 2012). Diet-induced obesity has been shown to
significantly increase the severity of post-traumatic KOA in a
common inbred strain of laboratory mice. More importantly,
levels of synovial inflammation in controlled uninjured knees
inversely correlates with systemic levels of adiponectin
(Louer et al., 2012).
Human studies
Adiponectin has not been detected in healthy cartilage and is
up-regulated in patients with OA (Francin et al., 2014). It has
been shown to be weakly associated with synovial inflam-
mation in patients with end-stage KOA (de Boer et al., 2012).
In human chondrocytes cultures, adiponectin induces MMP-3
(Tong et al., 2011). In patients with hand OA, high levels of
adiponectin have been associated with a 70% reduction of
joint space narrowing over a 6-year period (Yusuf et al.,
2011). Development of early symptomatic KOA has been
negatively associated with levels of adiponectin, and posi-
tively with high-sensitivity CRP (hs-CRP). Levels of
adiponectin have not been shown to predict progression or
incidence of radiographic KOA (Van Spil et al., 2012).
Decreased levels in both plasma and SF have been shown to
be lower in more advanced KOA, indicating that it may have a
protective role (Honsawek & Chayanupatkul, 2010).
Adiponectin has not been linked with an increase of bone
formation biomarkers so far (Berry et al., 2011).
In summary, higher systemic concentrations of adiponectin
probably protect against development of KOA in animal
models, while some clinical human studies also confirm
these properties. Despite this, adiponectin’s role in the
regulation of joint inflammation and cartilage homeostasis
is still not clear.
Resistin
The adipocytokine resistin was initially investigated mainly as
an insulin resistance inducing factor in mice (Steppan et al.,
2001). The receptor for resistin is unknown, but it has strong
pro-inflammatory properties and has been shown to trigger
the release of other proinflammatory cytokines such as
TNF- a, IL-1b and IL-6 (Bokarewa et al., 2005).
Human studies
Serum resistin is elevated in obese individuals (Degawa-
Yamauchi, 2003) but this correlation is obscured in patients
with advanced KOA (de Boer et al., 2012). In humans, resistin
correlates better with subclinical inflammation than with
insulin resistance (Steppan & Lazar, 2002). Resistin can be
detected locally in the synovium of patients with KOA and
correlates with histologically defined synovitis (de Boer et al.,
2012). Both systemic and SF concentrations are elevated in
post-traumatic knees and associated with the release of
cytokines and cartilage degeneration (Lee et al., 2009). In a
very early symptomatic KOA cohort, resistin levels have been
shown to be positively associated with synovial biomarkers
(sPIIINP) and high-sensitivity CRP but, more interestingly,
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with the incidence of radiographic KOA (Van Spil et al.,
2012). Such findings are independent of BMI and testing hs-
CRP as a potential confounder in this association has
suggested that those processes are independent.
Adipsin
Adipsin is involved in triglyceride metabolism but its effect
on cartilage and the rest of the knee joint is not yet known,
including any role in the modulation of synovitis after joint
trauma. Higher adipsin levels have been found in obese
individuals (Abu-Farha et al., 2014; Bienertova-Vasku et al.,
2014). Lower serum concentrations of adipsin have been
associated with greater painful joint burden in patients with
end-stage hip and knee OA (Perruccio et al., 2014).
Chemerin
Chemerin is a novel adipokine that affects adipocyte differen-
tiation and metabolism in vitro (MacDougald & Burant, 2007).
It acts through G protein-coupled receptor: the chemokine like
receptor-1 (CMKLR1, also known as ChemR23) and is
expressed by circulating plasmacytoid dendritic cells, tissue-
resident macrophages and adipocytes. It has been postulated
that chemerin increases macrophage infiltration and activates a
local inflammatory response (Goralski et al., 2007).
Stimulating human chondrocytes with chemerin results in an
increase in phosphorylation of Akt and a probable subsequent
activation of MEK1/2. It also further activates the MAPK
pathway and increases concentration of TNF-a, IL-1b, IL-6
and IL-8 (Berg et al., 2010). Along with this, it increases Toll-
like receptor 4 mRNA and the synthesis of CCL2 in OA
synoviocytes (Eisinger et al., 2012). The activated Toll-like
receptor 4 leads to the development of an inflammatory
reaction involving macrophages. CCL2 has been linked with
mediating movement-related pain signalling in the animal
model of post-traumatic KOA (Miller et al., 2012).
Animal studies
Mice bone marrow–derived osteoblast precursor cells differ-
entiate to adipocytes when stimulated by chemerin
(Muruganandan & Sinal, 2014). The increased bone mineral-
ization with chemerin, in the CMKLR1 knockdown model,
suggests that this signalling pathway acts, not only to promote
adipogenesis, but also to actively suppress osteoblastogenesis.
Human studies
Chemerin has been associated with visceral obesity (Shin
et al., 2012). High levels have been found to be associated
with the activity of inflammatory arthritis (rheumatoid and
psoriatic) (Ha et al., 2014; Xue et al., 2012). Chemerin is
detected in SF and its higher concentrations are associated
with KOA severity (Huang et al., 2012). SF levels of
chemerin are similar in patients with KOA, rheumatoid and
psoriatic arthritis (Valcamonica et al., 2014). Human chon-
drocyte cultures from patients with recent ACL injuries and
end-stage KOA cells have been positive for both ChemR23
and chemerin staining (Berg et al., 2010). Stimulation of those
cultures with chemerin has resulted in a significant elevation
of MMP-1, MMP-2, MMP-3, MMP-8 and MMP-13 levels,
catabolic enzymes associated with cartilage degeneration.
Visfatin
Visfatin is called pre-B-cell colony-enhancing factor and is
mainly produced by adipocytes in visceral fat and associated
with increases in insulin resistance (Fukuhara et al., 2005).
It regulates intracellular activity of the NAD-consuming
enzymes affecting the production of inflammatory cytokines
(TNFa, IL-6 and IL-1b) (Moschen et al., 2010). So far, no
specific receptor has been identified, but it is thought that
visfatin exerts proinflammatory action by regulating the
insulin receptor pathway activity (Jacques et al., 2012).
Human chondrocytes stimulated with visfatin induce synthe-
sis of MMP-3 and MMP-13 (Gosset et al., 2008).
Human studies
Higher levels are observed in subjects with broader waists
(Bienertova-Vasku et al., 2014) and associated with higher
triglicerides but lower HDL (Abu-Farha et al., 2014). Patients
with rheumatoid arthritis have higher serum levels of visfatin
than healthy controls (Otero et al., 2006). Vistafin has been
also shown to be produced and stored by synovial membrane,
cartilage and the subchondral bone in patients with KOA
(Laiguillon et al., 2014).
Summary
Animal research in this field, assessing the role of pro-
inflammatory cytokines related to adipose tissue in the
development of post-traumatic OA (PTOA), is very promis-
ing. Animals with impaired leptin pathways do not develop
KOA, even in the presence of extreme obesity, indicating that
increased loading cannot explain cartilage degeneration alone.
Higher leptin levels have been associated with more severe
progression of knee joint degeneration.
Leptin, resistin, chemerin and vistfatin have all been shown
to induce chondrocyte production of matrix metalloprotei-
nases. Based on the available literature on the involvement of
adipokines in post-traumatic KOA pathogenesis, it is plaus-
ible that adipokines (especially leptin in women), resistin and
chemerin (in men and women) may, in the future, contribute
to a risk model of early development of KOA after ACL
and/or meniscal injury. The relative activity of the various
adipokines with respect to their effects on the synovium, bone
and cartilage after knee trauma remains to be determined.
Local changes in adipokine concentrations may have import-
ant pathophysiological implications for cartilage homeostasis
but, so far, only leptin seems to correlate well with SF
concentration and the systematic elevation of resistin levels
has been proven to reflect SF concentration after joint injury.
This review identifies the need for prospective cohort
studies to investigate the role of serum and SF adipokines as
potential biomarkers for early post-traumatic OA in patients
with acute ACL and/or meniscal injuries. Long-term follow-
up will help to identify those at risk of a poor outcome and
identify possible therapeutic targets in this pathway.
522 S. Kluzek et al. Biomarkers, 2015; 20(8): 519–525
Declaration of interest
The authors declare no conflicts of interests. The authors alone
are are responsible for the content and writing of this article.
References
Abu-Farha M, Behbehani K, Elkum N. (2014). Comprehensive analysis
of circulating adipokines and hsCRP association with cardiovascular
disease risk factors and metabolic syndrome in Arabs. Cardiovasc
Diabetol 13:76.
Ahima RS. (2006). Adipose tissue as an endocrine organ. Obesity (Silver
Spring) 14:242s–9s.
Anderson JJ, Felson DT. (1988). Factors associated with osteoarthritis of
the knee in the first national Health and Nutrition Examination Survey
(HANES I). Evidence for an association with overweight, race, and
physical demands of work. Am J Epidemiol 128:179–89.
Arita Y, Kihara S, Ouchi N, et al. (1999). Paradoxical decrease of an
adipose-specific protein, adiponectin, in obesity. Biochem Biophys
Res Commun 425:560–4.
Ayral X, Pickering EH, Woodworth TG, et al. (2005). Synovitis: a
potential predictive factor of structural progression of medial
tibiofemoral knee osteoarthritis – results of a 1 year longitudinal
arthroscopic study in 422 patients. Osteoarthr Cartil 13:361–7.
Bao JP, Chen WP, Feng J, et al. (2010). Leptin plays a catabolic role on
articular cartilage. Mol Biol Rep 37:3265–72.
Barenius B, Ponzer S, Shalabi A, et al. (2014). Increased risk of
osteoarthritis after anterior cruciate ligament reconstruction: a 14-year
follow-up study of a randomized controlled trial. Am J Sports Med 42:
1049–57.
Bartell SM, Rayalam S, Ambati S, et al. (2011). Central (ICV) leptin
injection increases bone formation, bone mineral density, muscle
mass, serum IGF-1, and the expression of osteogenic genes in leptin-
deficient ob/ob mice. J Bone Miner Res 26:1710–20.
Berg V, Sveinbjornsson B, Bendiksen S, et al. (2010). Human articular
chondrocytes express ChemR23 and chemerin; ChemR23 promotes
inflammatory signalling upon binding the ligand chemerin(21-157).
Arthritis Res Ther 12:R228.
Berry PA, Jones SW, Cicuttini FM, et al. (2011). Temporal relationship
between serum adipokines, biomarkers of bone and cartilage turnover,
and cartilage volume loss in a population with clinical knee
osteoarthritis. Arthritis Rheum 63:700–7.
Bienertova-Vasku J, Novak J, Zlamal F, et al. (2014). The prediction role
of indexes of circulating adipokines for common anthropometric and
nutritional characteristics of obesity in the obese Central European
population. Eat Behav 15:244–51.
Blagojevic M, Jinks C, Jeffery A, Jordan KP. (2010). Risk factors for
onset of osteoarthritis of the knee in older adults: a systematic review
and meta-analysis. Osteoarthr Cartil/OARS, Osteoarthritis Res Soc
18:24–33.
Bokarewa M, Nagaev I, Dahlberg L, et al. (2005). Resistin, an adipokine
with potent proinflammatory properties. J Immunol 174:5789–95.
Bozaoglu K, Bolton K, McMillan J, et al. (2007). Chemerin is a novel
adipokine associated with obesity and metabolic syndrome.
Endocrinology 148:4687–94.
Bruun JM, Lihn AS, Verdich C, et al. (2003). Regulation of adiponectin
by adipose tissue-derived cytokines: in vivo and in vitro investigations
in humans. Am J Physiol Endocrinol Metab 285:E527–33.
Carbone F, La Rocca C, Matarese G. (2012). Immunological functions of
leptin and adiponectin. Biochimie 94:2082–8.
Combs TP, Berg AH, Rajala MW, et al. (2003). Sexual differentiation,
pregnancy, calorie restriction, and aging affect the adipocyte-specific
secretory protein adiponectin. Diabetes 52:268–76.
Cristancho AG, Lazar MA. (2011). Forming functional fat: a growing
understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 12:
722–34.
Davis MA, Ettinger WH, Neuhaus JM, et al. (1989). The association of
knee injury and obesity with unilateral and bilateral osteoarthritis of
the knee. Am J Epidemiol 130:278–88.
de Boer TN, van Spil WE, Huisman AM, et al. (2012). Serum adipokines
in osteoarthritis; comparison with controls and relationship with local
parameters of synovial inflammation and cartilage damage.
Osteoarthr Cartil 20:846–53.
Degawa-Yamauchi M. (2003). Serum resistin (FIZZ3) protein
is increased in obese humans. J Clin Endocrinol Metabol 88:5452–5.
Ding C, Parameswaran V, Cicuttini F, et al. (2008). Association between
leptin, body composition, sex and knee cartilage morphology in older
adults: the Tasmanian older adult cohort (TASOAC) study. Ann
Rheum Dis 67:1256–61.
Dumond H, Presle N, Terlain B, et al. (2003). Evidence for a key role of
leptin in osteoarthritis. Arthritis Rheum 48:3118–29.
Eisinger K, Bauer S, Schaffler A, et al. (2012). Chemerin induces CCL2
and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis
and osteoarthritis. Exp Mol Pathol 92:90–6.
Englund M, Roos EM, Lohmander LS. (2003). Impact of type of
meniscal tear on radiographic and symptomatic knee osteoarthritis: a
sixteen-year followup of meniscectomy with matched controls.
Arthritis Rheum 48:2178–87.
Fantuzzi G. (2005). Adipose tissue, adipokines, and inflammation.
J Allergy Clin Immunol 115:911–19; quiz 920.
Fasshauer M, Kralisch S, Klier M, et al. (2003). Adiponectin gene
expression and secretion is inhibited by interleukin-6 in 3T3-L1
adipocytes. Biochem Biophys Res Commun 301:1045–50.
Felson DT, Anderson JJ, Naimark A, et al. (1988). Obesity and knee
osteoarthritis. The Framingham Study. Ann Intern Med 109:18–24.
Figenschau Y, Knutsen G, Shahazeydi S, et al. (2001). Human articular
chondrocytes express functional leptin receptors. Biochem Biophys
Res Commun 287:190–7.
Francin PJ, Abot A, Guillaume C, et al. (2014). Association between
adiponectin and cartilage degradation in human osteoarthritis.
Osteoarthr Cartil 22:519–26.
Frobell RB, Roos EM, Roos HP, et al. (2010). A randomized trial of
treatment for acute anterior cruciate ligament tears. New Engl J Med
363:331–42.
Frobell RB, Roos HP, Roos EM, et al. (2013). Treatment for acute
anterior cruciate ligament tear: five year outcome of randomised trial.
Br Med J 346:f232.
Fukuhara A, Matsuda M, Nishizawa M, et al. (2005). Visfatin: a protein
secreted by visceral fat that mimics the effects of insulin. Science 307:
426–30.
Gianotti SM, Marshall SW, Hume PA, Bunt L. (2009). Incidence of
anterior cruciate ligament injury and other knee ligament injuries: a
national population-based study. J Sci Med Sport 12:622–7.
Goralski KB, McCarthy TC, Hanniman EA, et al. (2007). Chemerin, a
novel adipokine that regulates adipogenesis and adipocyte metabol-
ism. J Biol Chem 282:28175–88.
Gosset M, Berenbaum F, Salvat C, et al. (2008). Crucial role of visfatin/
pre-B cell colony-enhancing factor in matrix degradation and
prostaglandin E2 synthesis in chondrocytes: possible influence on
osteoarthritis. Arthritis Rheum 58:1399–409.
Griffin TM, Huebner JL, Kraus VB, et al. (2012). Induction of
osteoarthritis and metabolic inflammation by a very high-fat diet in
mice: effects of short-term exercise. Arthritis Rheum 64:443–53.
Griffin TM, Huebner JL, Kraus VB, Guilak F. (2009). Extreme obesity
due to impaired leptin signaling in mice does not cause knee
osteoarthritis. Arthritis Rheum 60:2935–44.
Guermazi A, Hayashi D, Roemer FW, et al. (2014). Synovitis in knee
osteoarthritis assessed by contrast-enhanced magnetic resonance
imaging (MRI) is associated with radiographic tibiofemoral osteo-
arthritis and MRI-detected widespread cartilage damage: the MOST
study. J Rheumatol 41:501–8.
Ha YJ, Kang EJ, Song JS, et al. (2014). Plasma chemerin levels in
rheumatoid arthritis are correlated with disease activity rather than
obesity. Joint Bone Spine 81:189–90.
Hamrick MW, Pennington C, Newton D, et al. (2004). Leptin deficiency
produces contrasting phenotypes in bones of the limb and spine. Bone
34:376–83.
Honsawek S, Chayanupatkul M. (2010). Correlation of plasma and
synovial fluid adiponectin with knee osteoarthritis severity. Arch Med
Res 41:593–8.
Huang K, Du G, Li L, et al. (2012). Association of chemerin levels in
synovial fluid with the severity of knee osteoarthritis. Biomarkers 17:
16–20.
Hui W, Litherland GJ, Elias MS, et al. (2012). Leptin produced by joint
white adipose tissue induces cartilage degradation via upregulation and
activation of matrix metalloproteinases. Ann Rheum Dis 71:455–62.
Jacques C, Holzenberger M, Mladenovic Z, et al. (2012).
Proinflammatory actions of visfatin/nicotinamide phosphoribosyl-
transferase (Nampt) involve regulation of insulin signaling pathway
and Nampt enzymatic activity. J Biol Chem 287:15100–8.
DOI: 10.3109/1354750X.2014.948914 Adipokines as biomarkers in post-traumatic knee osteoarthritis 523
Jiang L, Tian W, Wang Y, et al. (2012). Body mass index and
susceptibility to knee osteoarthritis: a systematic review and meta-
analysis. Joint Bone Spine 79:291–7.
Karvonen-Gutierrez CA, Harlow SD, Mancuso P, et al. (2013).
Association of leptin levels with radiographic knee osteoarthritis
among a cohort of midlife women. Arthritis Care Res (Hoboken) 65:
936–44.
Karvonen-Gutierrez CA, Harlow SD, Jacobson J, et al. (2014). The
relationship between longitudinal serum leptin measures and measures
of magnetic resonance imaging-assessed knee joint damage in a
population of mid-life women. Ann Rheum Dis 73:883–9.
Karvonen-Gutierrez CA, Sowers MR, Heeringa SG. (2012). Sex
dimorphism in the association of cardiometabolic characteristics and
osteophytes-defined radiographic knee osteoarthritis among obese and
non-obese adults: NHANES III. Osteoarthr Cartil 20:614–21.
Kessler MA, Behrend H, Henz S, et al. (2008). Function, osteoarthritis
and activity after ACL-rupture: 11 years follow-up results of
conservative versus reconstructive treatment. Knee Surg Sports
Traumatol Arthrosc 16:442–8.
Koskinen A, Vuolteenaho K, Nieminen R, et al. (2011). Leptin enhances
MMP-1, MMP-3 and MMP-13 production in human osteoarthritic
cartilage and correlates with MMP-1 and MMP-3 in synovial fluid
from OA patients. Clin Exp Rheumatol 29:57–64.
Kumada M, Kihara S, Ouchi N, et al. (2004). Adiponectin specifically
increased tissue inhibitor of metalloproteinase-1 through interleukin-
10 expression in human macrophages. Circulation 109:2046–9.
Laiguillon MC, Houard X, Bougault C, et al. (2014). Expression
and function of visfatin (Nampt), an adipokine-enzyme
involved in inflammatory pathways of osteoarthritis. Arthritis Res
Ther 16:R38.
Lebel B, Hulet C, Galaud B, et al. (2008). Arthroscopic reconstruction of
the anterior cruciate ligament using bone-patellar tendon-bone
autograft: a minimum 10-year follow-up. Am J Sports Med 36:
1275–82.
Lee MH, Klein RL, El-Shewy HM, et al. (2008). The adiponectin
receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-
dependent pathway and stimulate cell growth. Biochemistry 47:
11682–92.
Lee JH, Ort T, Ma K, et al. (2009). Resistin is elevated following
traumatic joint injury and causes matrix degradation and release of
inflammatory cytokines from articular cartilage in vitro. Osteoarthr
Cartil/OARS, Osteoarthritis Res Soc 17:613–20.
Li RT, Lorenz S, Xu Y, et al. (2011). Predictors of radiographic knee
osteoarthritis after anterior cruciate ligament reconstruction. Am J
Sports Med 39:2595–603.
Licinio J, Negrao AB, Mantzoros C, et al. (1998). Sex differences in
circulating human leptin pulse amplitude: clinical implications. J Clin
Endocrinol Metab 83:4140–7.
Lira FS, Rosa JC, Pimentel GD, et al. (2012). Both adiponectin and
interleukin-10 inhibit LPS-induced activation of the NF-kappaB
pathway in 3T3-L1 adipocytes. Cytokine 57:98–106.
Livshits G, Zhai G, Hart DJ, et al. (2009). Interleukin-6 is a significant
predictor of radiographic knee osteoarthritis: the Chingford Study.
Arthritis Rheum 60:2037–45.
Lohmander LS, Gerhardsson de Verdier M, Rollof J, et al. (2009).
Incidence of severe knee and hip osteoarthritis in relation to different
measures of body mass: a population-based prospective cohort study.
Ann Rheum Dis 68:490–6.
Lohmander LS, Ostenberg A, Englund M, Roos H. (2004). High
prevalence of knee osteoarthritis, pain, and functional limitations in
female soccer players twelve years after anterior cruciate ligament
injury. Arthrit Rheumat 50:3145–52.
Louer CR, Furman BD, Huebner JL, et al. (2012). Diet-induced obesity
significantly increases the severity of posttraumatic arthritis in mice.
Arthritis Rheum 64:3220–30.
MacDougald OA, Burant CF. (2007). The rapidly expanding family of
adipokines. Cell Metab 6:159–61.
Maeda N, Shimomura I, Kishida K, et al. (2002). Diet-induced insulin
resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731–7.
Majewski M, Susanne H, Klaus S. (2006). Epidemiology of athletic knee
injuries: a 10-year study. Knee 13:184–8.
Mendias CL, Lynch EB, Davis ME, et al. (2013). Changes in circulating
biomarkers of muscle atrophy, inflammation, and cartilage turnover in
patients undergoing anterior cruciate ligament reconstruction and
rehabilitation. Am J Sports Med 41:1819–26.
Miller RE, Tran PB, Das R, et al. (2012). CCR2 chemokine receptor
signaling mediates pain in experimental osteoarthritis. Proc Natl Acad
Sci USA 109:20602–7.
Moschen AR, Gerner RR, Tilg H. (2010). Pre-B cell colony enhancing
factor/NAMPT/visfatin in inflammation and obesity-related disorders.
Curr Pharm Des 16:1913–20.
Muruganandan S, Dranse HJ, Rourke JL, et al. (2013). Chemerin
neutralization blocks hematopoietic stem cell osteoclastogenesis.
Stem Cells 31:2172–82.
Muruganandan S, Roman AA, Sinal CJ. (2010). Role of chemerin/
CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone
marrow stem cells. J Bone Miner Res 25:222–34.
Muruganandan S, Sinal CJ. (2014). The impact of bone marrow
adipocytes on osteoblast and osteoclast differentiation. IUBMB Life.
Neuman P, Englund M, Kostogiannis I, et al. (2008). Prevalence of
tibiofemoral osteoarthritis 15 years after nonoperative treatment of
anterior cruciate ligament injury: a prospective cohort study. Am J
Sports Med 36:1717–25.
Ohba S, Lanigan TM, Roessler BJ. (2010). Leptin receptor JAK2/STAT3
signaling modulates expression of Frizzled receptors in articular
chondrocytes. Osteoarthr Cartil 18:1620–9.
Oliveria SA, Felson DT, Cirillo PA, et al. (1999). Body weight, body
mass index, and incident symptomatic osteoarthritis of the hand, hip,
and knee. Epidemiology 10:161–6.
Otero M, Lago R, Gomez R, et al. (2006). Changes in plasma levels of
fat-derived hormones adiponectin, leptin, resistin and visfatin in
patients with rheumatoid arthritis. Ann Rheum Dis 65:1198–201.
Perruccio AV, Mahomed NN, Chandran V, Gandhi R. (2014). Plasma
adipokine levels and their association with overall burden of painful
joints among individuals with hip and knee osteoarthritis. J Rheumatol
41:334–7.
Pessler F, Dai L, Diaz-Torne C, et al. (2008). The synovitis of ‘‘non-
inflammatory’’ orthopaedic arthropathies: a quantitative histological
and immunohistochemical analysis. Ann Rheumat Dis 67:1184–7.
Pirkola J, Vaarasmaki M, Ala-Korpela M, et al. (2010). Low-grade,
systemic inflammation in adolescents: association with early-life
factors, gender, and lifestyle. Am J Epidemiol 171:72–82.
Presle N, Pottie P, Dumond H, et al. (2006). Differential distribution of
adipokines between serum and synovial fluid in patients with
osteoarthritis. Contribution of joint tissues to their articular produc-
tion. Osteoarthr Cartil 14:690–5.
Proenca AR, Sertie RA, Oliveira AC, et al. (2014). New concepts in
white adipose tissue physiology. Braz J Med Biol Res 47:192–205.
Roemer FW, Guermazi A, Felson DT, et al. (2011). Presence of MRI-
detected joint effusion and synovitis increases the risk of cartilage loss
in knees without osteoarthritis at 30-month follow-up: the MOST
study. Ann Rheum Dis 70:1804–09.
Roemer FW, Zhang Y, Niu J, et al. (2009). Tibiofemoral joint
osteoarthritis: risk factors for MR-depicted fast cartilage loss over a
30-month period in the multicenter osteoarthritis study. Radiology
252:772–80.
Roos EM. (2005). Joint injury causes knee osteoarthritis in young adults.
Curr Opin Rheumatol 17:195–200.
Shin HY, Lee DC, Chu SH, et al. (2012). Chemerin levels are positively
correlated with abdominal visceral fat accumulation. Clin Endocrinol
(Oxf) 77:47–50.
Sokolove J, Lepus CM. (2013). Role of inflammation in the pathogenesis
of osteoarthritis: latest findings and interpretations. Ther Adv
Musculoskelet Dis 5:77–94.
Staikos C, Ververidis A, Drosos G, et al. (2013). The association of
adipokine levels in plasma and synovial fluid with the severity of knee
osteoarthritis. Rheumatology (Oxford) 52:1077–83.
Stannus OP, Cao Y, Antony B, et al. (2013). Cross-sectional and
longitudinal associations between circulating leptin and knee cartilage
thickness in older adults. Ann Rheum Dis 72:535–40.
Steppan CM, Bailey ST, Bhat S, et al. (2001). The hormone resistin links
obesity to diabetes. Nature 409:307–12.
Steppan CM, Lazar MA. (2002). Resistin and obesity-associated insulin
resistance. Trends Endocrinol Metab 13:18–23.
Tong KM, Chen CP, Huang KC, et al. (2011). Adiponectin increases
MMP-3 expression in human chondrocytes through AdipoR1 signal-
ing pathway. J Cell Biochem 112:1431–40.
Tsatsanis C, Zacharioudaki V, Androulidaki A, et al. (2005). Adiponectin
induces TNF-alpha and IL-6 in macrophages and promotes tolerance
524 S. Kluzek et al. Biomarkers, 2015; 20(8): 519–525
to itself and other pro-inflammatory stimuli. Biochem Biophys Res
Commun 335:1254–63.
Valcamonica E, Chighizola CB, Comi D, et al. (2014). Levels of
chemerin and interleukin 8 in the synovial fluid of patients with
inflammatory arthritides and osteoarthritis. Clin Exp Rheumatol 32:
243–50.
Van Spil WE, Welsing PM, Kloppenburg M, et al. (2012). Cross-
sectional and predictive associations between plasma adipokines and
radiographic signs of early-stage knee osteoarthritis: data from
CHECK. Osteoarthr Cartil 20:1278–85.
Visser AW, de Mutsert R, Loef M, et al. (2014). The role of fat mass and
skeletal muscle mass in knee osteoarthritis is different for men and
women: the NEO study. Osteoarthr Cartil 22:197–202.
von Porat A. (2004). High prevalence of osteoarthritis 14 years after an
anterior cruciate ligament tear in male soccer players: a study of
radiographic and patient relevant outcomes. Ann Rheumat Dis 63:
269–73.
Weiss E. (2014). Knee osteoarthritis, body mass index and
pain: data from the Osteoarthritis Initiative. Rheumatology
(Oxford).
Wolf AM, Wolf D, Rumpold H, et al. (2004). Adiponectin induces the
anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes.
Biochem Biophys Res Commun 323:630–5.
Xue Y, Jiang L, Cheng Q, et al. (2012). Adipokines in psoriatic arthritis
patients: the correlations with osteoclast precursors and bone erosions.
PLoS One 7:e46740.
Yusuf E, Ioan-Facsinay A, Bijsterbosch J, et al. (2011).
Association between leptin, adiponectin and resistin and long-
term progression of hand osteoarthritis. Ann Rheum Dis 70:
1282–4.
DOI: 10.3109/1354750X.2014.948914 Adipokines as biomarkers in post-traumatic knee osteoarthritis 525
